Goldman Sachs
EDVA

Goldman Sachs’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Goldman Sachs’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Buy
+5,101
New +$5.28K ﹤0.01% 6509

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Goldman Sachs's EDVA Position: Q2 2026 in Review

Goldman Sachs opened a new position in Endovia Health Sciences, Inc. (EDVA) in Q2 2026: 5,101 shares worth $3.16K. The stake represents ﹤0.01% of the portfolio and ranks #6509 among its holdings.

18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • Goldman Sachs held 5,101 shares of Endovia Health Sciences, Inc. worth $3.16K as of Q2 2026.
  • Endovia Health Sciences, Inc. was a new Goldman Sachs position in Q2 2026.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6509 holding.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.